Chuning Biotech: The methanol protein project is one of the company's core projects. Currently, the project is undergoing related improvement experiments based on feedback from downstream customers.

Everyday AI Express, an investor asked on the investor interaction platform: Regarding the methanol protein project, the company previously stated that it expected to obtain the final results of the pilot test by the end of last year. Are there any results now? Based on the company’s earlier research on this project, what is the market outlook? If it is successfully built and put into production in the future, will it become one of the company’s key core projects? Will it significantly increase the company’s market value? Thank you.

Chuaning Bio (301301.SZ) stated on the investor interaction platform on March 5 that the methanol protein project is one of the company’s key projects. Currently, the project is undergoing related improved experiments based on feedback from downstream customers. Methanol protein has broad prospects for industrial production. It is a single-cell protein produced by cultivating microorganisms using methanol as a carbon source. It has advantages such as low cost, stable and controllable quality, and is also considered an effective substitute for edible and feed proteins.

(Reporter Zeng Jianhui)

Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Verify before use. Operate at your own risk.

Everyday Economic News

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin